Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Merkelbach-Bruse

Showing results (41-50 of 162) with videos related to

Pageof 17
Sort By:
Oncotarget|January 19, 2015
c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasiaKirsten Kübler, Sally Heinenberg, Christian Rudlowski, et al.
Computational and Structural Biotechnology Journal|November 26, 2019
Comparison of <i>in situ</i> and extraction-based methods for the detection of <i>MET</i> amplifications in solid tumorsCarina Heydt, Ann-Kathrin Becher, Svenja Wagener-Ryczek, et al.
Cancers|October 27, 2022
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET AlterationsGabriele Gamerith, Marcel Kloppenburg, Finn Mildner, et al.
BMC Cancer|January 14, 2014
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutationsMichaela Angelika Ihle, Jana Fassunke, Katharina König, et al.
Biomolecules|October 27, 2022
Teenage-Onset Colorectal Cancers in a Digenic Cancer Predisposition Syndrome Provide Clues for the Interaction between Mismatch Repair and Polymerase δ Proofreading Deficiency in TumorigenesisEsther Schamschula, Miriam Kinzel, Annekatrin Wernstedt, et al.
Oncotarget|June 4, 2015
FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitroHelen Künstlinger, Jana Fassunke, Hans-Ulrich Schildhaus, et al.
Scientific Reports|July 11, 2020
Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencingCarina Heydt, Jan Rehker, Roberto Pappesch, et al.
Plos One|August 9, 2014
Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnosticsCarina Heydt, Jana Fassunke, Helen Künstlinger, et al.
The Journal of Pathology|October 11, 2005
Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 stainingElisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl, et al.
Human Pathology|May 3, 2011
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumorsHans-Ulrich Schildhaus, Raffael Riegel, Wolfgang Hartmann, et al.
Pageof 17

Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
Oncotarget|January 19, 2015
c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasiaKirsten Kübler, Sally Heinenberg, Christian Rudlowski, et al.
Computational and Structural Biotechnology Journal|November 26, 2019
Comparison of <i>in situ</i> and extraction-based methods for the detection of <i>MET</i> amplifications in solid tumorsCarina Heydt, Ann-Kathrin Becher, Svenja Wagener-Ryczek, et al.
Cancers|October 27, 2022
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET AlterationsGabriele Gamerith, Marcel Kloppenburg, Finn Mildner, et al.
BMC Cancer|January 14, 2014
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutationsMichaela Angelika Ihle, Jana Fassunke, Katharina König, et al.
Biomolecules|October 27, 2022
Teenage-Onset Colorectal Cancers in a Digenic Cancer Predisposition Syndrome Provide Clues for the Interaction between Mismatch Repair and Polymerase δ Proofreading Deficiency in TumorigenesisEsther Schamschula, Miriam Kinzel, Annekatrin Wernstedt, et al.
Oncotarget|June 4, 2015
FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitroHelen Künstlinger, Jana Fassunke, Hans-Ulrich Schildhaus, et al.
Scientific Reports|July 11, 2020
Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencingCarina Heydt, Jan Rehker, Roberto Pappesch, et al.
Plos One|August 9, 2014
Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnosticsCarina Heydt, Jana Fassunke, Helen Künstlinger, et al.
The Journal of Pathology|October 11, 2005
Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 stainingElisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl, et al.
Human Pathology|May 3, 2011
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumorsHans-Ulrich Schildhaus, Raffael Riegel, Wolfgang Hartmann, et al.
Pageof 17